Hextend (Hospira, Inc.)
Welcome to the PulseAid listing for the Hextend drug offered from Hospira, Inc.. This Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hospira, Inc. |
NON-PROPRIETARY NAME: | HETASTARCH |
SUBSTANCE NAME: | HETASTARCH |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1999-03-31 |
END MARKETING DATE: | 0000-00-00 |
Hextend HUMAN PRESCRIPTION DRUG Details:
Item Description | Hextend from Hospira, Inc. |
LABELER NAME: | Hospira, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6(g/100mL) |
START MARKETING DATE: | 1999-03-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0409-1555_aea5152b-6373-4a47-84f5-d9d499eaf7d3 |
PRODUCT NDC: | 0409-1555 |
APPLICATION NUMBER: | BN200952 |
Other HETASTARCH Pharmaceutical Manufacturers / Labelers: